News
-
Mar042020
Pulmonary Fibrosis Foundation Launches Industry Consortium To Identify Biomarkers In Pulmonary Fibrosis
The Pulmonary Fibrosis Foundation and Celgene Corporation, a wholly owned subsidiary of Bristol-Myers Squibb Company, have created a consortium called PROLIFIC (Prognostic Lung Fibrosis Consortium) to develop well-qualified assays to detect important peripheral blood protein biomarkers in patients with pulmonary fibrosis. The assays will be used to uncover early indicators of a drug’s activity.Read Full Article Pulmonary Fibrosis Foundation Launches Industry Consortium To Identify Biomarkers In Pulmonary Fibrosis -
Feb242020
86% of Americans Do Not Know Symptoms of Pulmonary Fibrosis
Pulmonary Fibrosis Foundation National Awareness Survey reveals little understanding of disease in advance of Rare Disease Week.Read Full Article 86% of Americans Do Not Know Symptoms of Pulmonary Fibrosis -
Feb072020
Bernadette Peters, Broadway Stars Unite To Perform In Pulmonary Fibrosis Benefit
Multi-Tony Award-Winner, Bernadette Peters (Hello, Dolly!, Follies, A Little Night Music), along with New York’s theatrical community, will raise funds and awareness for pulmonary fibrosis (PF), a debilitating lung disease, in the 10th annual Broadway Belts for PFF!Read Full Article Bernadette Peters, Broadway Stars Unite To Perform In Pulmonary Fibrosis Benefit -
Jan082020
Pulmonary Fibrosis Foundation Support Groups Benefit From Leanne Storch Support Group Fund Grants
The Pulmonary Fibrosis Foundation (PFF) today announced that 59 pulmonary fibrosis (PF) support groups nationwide received grants from the 2019 Leanne Storch Support Group Fund. The Fund is sponsored by Boehringer Ingelheim and Genentech, a Roche company. Named for the PFF’s former executive director who was diagnosed with PF in 2003, the Leanne Storch Support Group Fund honors her passion for supporting those affected by the disease.Read Full Article Pulmonary Fibrosis Foundation Support Groups Benefit From Leanne Storch Support Group Fund Grants -
Nov042019
NIH Awards Major Grant In Pulmonary Fibrosis Research
The Pulmonary Fibrosis Foundation announced the launch of PRECISIONS, a study that aims to transform the diagnosis and treatment of idiopathic pulmonary fibrosis (IPF), by moving it into the era of precision medicine.Read Full Article NIH Awards Major Grant In Pulmonary Fibrosis Research -
Sep042019
Three Lakes Partners And Pulmonary Fibrosis Foundation Partner In Fight Against Pulmonary Fibrosis
Commit To Drive Disease Awareness, Expand Research And Patient AdvocacyRead Full Article Three Lakes Partners And Pulmonary Fibrosis Foundation Partner In Fight Against Pulmonary Fibrosis